(NYSE: TFX) Teleflex's forecast annual revenue growth rate of -3.29% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.79%.
Teleflex's revenue in 2026 is $2,811,156,000.On average, 14 Wall Street analysts forecast TFX's revenue for 2026 to be $102,264,187,410, with the lowest TFX revenue forecast at $98,943,921,585, and the highest TFX revenue forecast at $106,602,668,088. On average, 14 Wall Street analysts forecast TFX's revenue for 2027 to be $107,310,991,464, with the lowest TFX revenue forecast at $103,636,563,951, and the highest TFX revenue forecast at $112,047,904,041.
In 2028, TFX is forecast to generate $112,623,416,784 in revenue, with the lowest revenue forecast at $108,417,746,739 and the highest revenue forecast at $117,980,112,315.